Does the evidence support population-wide screening for type 2 diabetes? No
- PMID: 28831520
- DOI: 10.1007/s00125-017-4393-1
Does the evidence support population-wide screening for type 2 diabetes? No
Abstract
Large-scale, centrally-coordinated screening for undiagnosed type 2 diabetes is an attractive option to reduce the mortality and morbidity resulting from inadequately controlled diabetes. However, there is limited research examining the direct consequences of such screening programmes on outcomes such as cardiovascular disease and death. Two papers published in this edition of Diabetologia (DOIs: 10.1007/s00125-017-4323-2 and 10.1007/s00125-017-4299-y ) examine data from one of the very few trials conducted in this area. Overall, there was little benefit that could be directly related to the screening programme. In part, this was due to the high levels of opportunistic screening in the control group. Thus, when there are high levels of opportunistic screening for type 2 diabetes, there remains no clear evidence of benefit of centrally-coordinated screening programmes that approach individuals outside usual healthcare settings.
Keywords: Cardiovascular disease; Mortality; Screening; Type 2 diabetes.
Comment on
-
Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.Diabetologia. 2017 Nov;60(11):2183-2191. doi: 10.1007/s00125-017-4323-2. Epub 2017 Aug 23. Diabetologia. 2017. PMID: 28831535 Free PMC article. Clinical Trial.
-
Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.Diabetologia. 2017 Nov;60(11):2192-2199. doi: 10.1007/s00125-017-4299-y. Epub 2017 Aug 23. Diabetologia. 2017. PMID: 28831539 Free PMC article. Clinical Trial.
Similar articles
-
Should we screen for type 2 diabetes among asymptomatic individuals? Yes.Diabetologia. 2017 Nov;60(11):2148-2152. doi: 10.1007/s00125-017-4397-x. Epub 2017 Aug 23. Diabetologia. 2017. PMID: 28831523
-
Screening for type 2 diabetes: literature review and economic modelling.Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. doi: 10.3310/hta11170. Health Technol Assess. 2007. PMID: 17462167 Review.
-
Screening for type 2 diabetes: a short report for the National Screening Committee.Health Technol Assess. 2013 Aug;17(35):1-90. doi: 10.3310/hta17350. Health Technol Assess. 2013. PMID: 23972041 Free PMC article. Review.
-
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.Trials. 2010 Feb 19;11:16. doi: 10.1186/1745-6215-11-16. Trials. 2010. PMID: 20170482 Free PMC article. Clinical Trial.
-
Health dialogue intervention versus opportunistic screening in primary care for type 2 diabetes and cardiovascular disease prevention in settings with low socioeconomic status (DETECT): study protocol for a pragmatic cluster-randomized trial.Trials. 2024 Oct 12;25(1):672. doi: 10.1186/s13063-024-08533-8. Trials. 2024. PMID: 39394167 Free PMC article.
Cited by
-
All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany.BMJ Open Diabetes Res Care. 2017 Dec 16;5(1):e000451. doi: 10.1136/bmjdrc-2017-000451. eCollection 2017. BMJ Open Diabetes Res Care. 2017. PMID: 29435349 Free PMC article.
-
Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.Cardiovasc Diabetol. 2018 Jan 24;17(1):21. doi: 10.1186/s12933-018-0665-4. Cardiovasc Diabetol. 2018. PMID: 29368616 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical